Medyria

medical devices

About

Medyria is a Swiss MedTech start-up founded in 2013 by Dr. Mauro Sette. The company specializes in innovative cardiovascular medical technologies aimed at enhancing patient and physician safety while simplifying procedures and reducing costs. Headquartered in Technopark Winterthur, Switzerland, Medyria has facilities for administration, quality control, production, and research and development. The company's core technology focuses on blood flow velocity (BFV) sensing, which allows for real-time assessment of heart function during interventional cardiology procedures. Their flagship product, the PyCath, is a microcatheter that integrates BFV measurement, improving diagnostic accuracy and patient eligibility for treatment in angina pectoris cases. Medyria also supplies its BFV sensing technology to other manufacturers through an OEM business model, supporting innovation in cardiovascular diagnostics. With a strong intellectual property portfolio and successful funding rounds, Medyria is dedicated to advancing its technologies for better patient outcomes in cardiovascular care.

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Wix Mobile Friendly Varnish Android AI

Keywords

medical devices evar technopark winterthur swiss startups nocad microvascular disease diagnosis microvascular assessment healthcare equipment & supplies pycath system minimally invasive cardiology interventional cardiology coronary artery disease blood flow velocity ffr cardiovascular diagnostics diagnostic device microvascular resistance coronary physiology sensor integration in catheters real-time data catheter system micro sensors micro device for cardiology medical device development blood flow analysis clinical diagnostics sensor technology physiological parameters medical sensors

Location

2 Technoparkstrasse, Winterthur, Zurich, Switzerland, 8406

Related Companies

Companies in the same industry